Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1Cervical

Calculate your site FeedRank Today

FeedRank, a newly developed algorithm for ranking RSS feeds only on RSSMicro
Click here to learn more

Drugs.com - Clinical Trials

5/10 Good --- feeds.drugs.com

http://feeds.drugs.com/Drugscom-ClinicalTrials

Latest updates on trial results from clinical trials currently in progress. ...

Preview | Subscribe | Posts

Nventa Completes Safety Evaluation on Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial

Saturday, April 26, 2008 --- 91 days ago

http://feeds.drugs.com/~r/Drugscom-ClinicalTrials/~3/277617090/nventa-completes-

- HspE7 Phase 2 Trial for Cervical Dysplasia to Begin Mid-2008 - SAN DIEGO, April 24 /CNW/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) today announced the completion of the safety and tolerability assessment of the fourth and final cohort... ...

Recent Posts

Ardea to Present Data on Lead HIV Candidate, RDEA806, at XVII International AIDS Conference - 6 days ago
Biovest Reports Results for Patients Treated with Anti-Cancer Vaccine: BiovaxID Demonstrates Clinically and Statistically Significant Improvement of Disease-Free Survival in Non-Hodgkin's Lymphoma in Pivotal Phase 3 Clinical Trial - 6 days ago
Nemours Center for Childhood Cancer Research Team at the Alfred I. duPont Hospital for Children Identifies the Function of a Biomarker Present in Prostate Cancer Cells: New Insight into Therapeutic Benefit for Patients with Advanced Prostate Cancer - 6 days ago
Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimer's Disease - 6 days ago
Resverlogix's Lead Drug Featured in Key Scientific Publication - 6 days ago
Repros Therapeutics Inc. Announces That Initial Findings for Proellex Show No Tumorigenic Response in a Two-year Carcinogenicity Study in Rats - 6 days ago
Cyclacel Publishes Study of Seliciclib Synergy with Tarceva and Herceptin in Journal Clinical Cancer Research - 9 days ago
Cardiome to Hold Conference Call - 9 days ago
ADAGIO Phase III Top Line Data to be Presented at 12th Congress of European Federation of Neurological Societies - 9 days ago
Eight-Year Melanoma Remission is Among Early Cancer Treatment Results - 9 days ago
Mesoblast Limited Announce Pre-clinical Trials Show Allogenic Stem Cells Effectively Treat Eye Diseases - 14 days ago
Repros Therapeutics Inc. Announces That Proellex Significantly Reduces Pain in a U.S. Phase 2 Clinical Trial in Women with Moderate to Severe Endometriosis - 14 days ago
Pharming Announces Positive Results From Rhucin Open-label Clinicial Studies - 14 days ago
Neuron to Publish Prana's PBT2 Preclinical Research - 14 days ago
Mesoblast Limited (ASX:MSB) Announce Pre-clinical Trials Show Allogenic Stem Cells Effectively Treat Eye Diseases - 14 days ago

All posts on this feed

All feeds on drugs.com

Facebook

Del.icio.us

Digg

StumbleUpon

Google

	Copyright © 2008 RSSMicro.com